Cardizem Cd is a drug owned by Bausch Health Us Llc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 08, 2012. Details of Cardizem Cd's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5439689 | Diltiazem formulation |
Aug, 2012
(12 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Cardizem Cd is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Cardizem Cd's family patents as well as insights into ongoing legal events on those patents.
Cardizem Cd's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Cardizem Cd's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 08, 2012 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Cardizem Cd Generic API suppliers:
Diltiazem Hydrochloride is the generic name for the brand Cardizem Cd. 37 different companies have already filed for the generic of Cardizem Cd, with Actavis Labs Fl Inc having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Cardizem Cd's generic
How can I launch a generic of Cardizem Cd before its drug patent expiration? :
You can seek FDA approval to launch a generic drug before the expiration of Cardizem Cd's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Cardizem Cd's sponsor is invalid, unenforceable, or will not be infringed by your generic product.
Given below are the details of the already filed Para IV certificates on Cardizem Cd -
| Strength | Submission Date | ANDA(s) Filed | First applicant approval | Last patent expiry | 180 day status |
|---|---|---|---|---|---|
| 120 mg, 180 mg, 240 mg, 300 mg and 360 mg |
Alternative Brands for Cardizem Cd
Cardizem Cd which is used for treating hypertension and angina pectoris., has several other brand drugs in the same treatment category and using the same active ingredient (Diltiazem Hydrochloride). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | Treatment Area | ||
|---|---|---|---|---|
| Bausch |
| |||
Apart from drugs working in same treatment category, there are also some brand drugs where treatment area is different, but the active ingredient used is same i.e. Diltiazem Hydrochloride. Given below is the list of those drugs and companies owning them.
| Drug Owner | Drug Name | |
|---|---|---|
| Bausch |
| |
| Biovail |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Diltiazem Hydrochloride, Cardizem Cd's active ingredient. Check the complete list of approved generic manufacturers for Cardizem Cd
About Cardizem Cd
Cardizem Cd is a drug owned by Bausch Health Us Llc. It is used for treating hypertension and angina pectoris. Cardizem Cd uses Diltiazem Hydrochloride as an active ingredient. Cardizem Cd was launched by Bausch in 1992.
Approval Date:
Cardizem Cd was approved by FDA for market use on 10 August, 1992.
Active Ingredient:
Cardizem Cd uses Diltiazem Hydrochloride as the active ingredient. Check out other Drugs and Companies using Diltiazem Hydrochloride ingredient
Treatment:
Cardizem Cd is used for treating hypertension and angina pectoris.
Dosage:
Cardizem Cd is available in capsule, extended release form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 120MG | CAPSULE, EXTENDED RELEASE | Prescription | ORAL |
| 180MG | CAPSULE, EXTENDED RELEASE | Prescription | ORAL |
| 240MG | CAPSULE, EXTENDED RELEASE | Prescription | ORAL |
| 300MG | CAPSULE, EXTENDED RELEASE | Prescription | ORAL |
| 360MG | CAPSULE, EXTENDED RELEASE | Prescription | ORAL |